On August 14, 2024, Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) conducted its 2024 Annual and Special Meeting of Shareholders in Fort Lauderdale, Florida. The meeting was held to discuss various proposals that were put to a vote by the Company’s shareholders.
Proposal 1 involved the election of four directors to the Board of Directors of Flora Growth Corp. These directors would hold office until the Company’s 2025 Annual Meeting of Shareholders or until their respective successors are elected or appointed. The final voting results for the directors are as follows:
– Clifford Starke: For – 4,969,741; Against – 97,612; Abstentions – 18,969; Non-Votes – 2,778,760
– Kevin Taylor: For – 4,931,118; Against – 129,648; Abstentions – 25,556; Non-Votes – 2,778,760
– Edward Woo: For – 4,881,581; Against – 179,654; Abstentions – 25,087; Non-Votes – 2,778,760
– Brendan Cahill: For – 5,001,476; Against – 57,680; Abstentions – 27,166; Non-Votes – 2,778,760
Proposal 2 involved the reappointment of Davidson & Company LLP as auditors of Flora Growth Corp. for the fiscal year ending December 31, 2024. Shareholders voted in favor of this proposal, with 7,499,363 votes for and 323,623 votes against.
Proposal 3 centered around the approval of an amendment to the Company’s 2022 Incentive Compensation Plan to increase the number of shares issuable from 950,000 to 2,500,000 shares. Shareholders voted in favor of this proposal, with 4,776,425 votes for, 285,446 votes against, and 24,451 abstentions.
Proposal 4 involved the approval of the grant of stock appreciation rights to the Company’s Chief Executive Officer and Chief Financial Officer. Shareholders voted in favor of this proposal, with 4,802,189 votes for, 253,288 votes against, and 30,845 abstentions.
Proposal 5 pertained to the approval of the issuance of 635,363 shares to acquire the minority interest of TruHC Pharma GmbH. Shareholders voted in favor of this proposal, with 4,249,883 votes for, 184,837 votes against, and 26,704 abstentions.
No other matters were discussed or voted upon at the Annual Meeting.
Flora Growth Corp. is a leading consumer-packaged goods and pharmaceutical distributor with a widespread presence across 50 states and 28 countries, encompassing 20,000+ points of distribution globally. For more information on Flora Growth Corp., please visit their website at www.floragrowth.com.
Please note that this press release may contain forward-looking statements subject to various risks and uncertainties. It is advisable to refer to Flora’s filings with the SEC for more comprehensive information on these forward-looking statements. Flora disclaims any obligation to update or revise any forward-looking statement based on new information or future events.
For the original source of this press release, please visit https://www.newsfilecorp.com/release/219906.
